S925-0325 Screening compound: N-[(1,4-dimethyl-5-oxo-6-phenylpiperazin-2-yl)methyl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide

S925-0325 Screening compound: N-[(1,4-dimethyl-5-oxo-6-phenylpiperazin-2-yl)methyl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide
S925-0325 Screening compound: N-[(1,4-dimethyl-5-oxo-6-phenylpiperazin-2-yl)methyl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S925-0325
N-[(1,4-dimethyl-5-oxo-6-phenylpiperazin-2-yl)methyl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S925-0325

Molecular Formula

C23H29N3O3S (C23 H29 N3 O3 S)

Compound Name

N-[(1,4-dimethyl-5-oxo-6-phenylpiperazin-2-yl)methyl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide

IUPAC name

N-{[(2S6S)-14-dimethyl-5-oxo-6-phenylpiperazin-2-yl]methyl}-5678-tetrahydronaphthalene-2-sulfonamide

SMILES

CN(C[C@@H](CNS(c1cc(CCCC2)c2cc1)(=O)=O)N(C)[C@H]1c2ccccc2)C1=O

InChI

InChI=1S/C23H29N3O3S/c1-25-16-20(26(2)22(23(25)27)18-9-4-3-5-10-18)15-24-30(28,29)21-13-12-17-8-6-7-11-19(17)14-21/h3-5,9-10,12-14,20,22,24H,6-8,11,15-16H2,1-2H3/t20-,22+/m1/s1

InChI Key

SHQUMHYCAVYNNK-IRLDBZIGSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.490

Distribution Coefficient, logD

3.489

Water Solubility, LogSw

-3.82

Polar Surface Area

60.911

Acid Dissociation Constant (pKa)

11.63

Base Dissociation Constant (pKb)

4.79

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

43.48

S925-0325 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

Natural-Product-Based Library (3730 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
Targets:
  • Kinases
  • GPCR
  • Ion Channels
Structure:
  • Pool
  • Mimetics
  • Cyclic compounds
  • Mimetics
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with S925-0325 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S925-0325?
Check Price and Availability of S925-0325, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S925-0325 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S925-0325
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S925-0325
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S925-0325 available by request